PMC:7283670 / 85454-86344
Annnotations
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T285","span":{"begin":207,"end":217},"obj":"Body_part"},{"id":"T286","span":{"begin":280,"end":286},"obj":"Body_part"},{"id":"T287","span":{"begin":358,"end":364},"obj":"Body_part"},{"id":"T288","span":{"begin":372,"end":378},"obj":"Body_part"},{"id":"T289","span":{"begin":440,"end":446},"obj":"Body_part"},{"id":"T290","span":{"begin":484,"end":490},"obj":"Body_part"},{"id":"T291","span":{"begin":507,"end":513},"obj":"Body_part"},{"id":"T292","span":{"begin":554,"end":560},"obj":"Body_part"},{"id":"T293","span":{"begin":654,"end":660},"obj":"Body_part"}],"attributes":[{"id":"A285","pred":"fma_id","subj":"T285","obj":"http://purl.org/sig/ont/fma/fma62863"},{"id":"A286","pred":"fma_id","subj":"T286","obj":"http://purl.org/sig/ont/fma/fma7203"},{"id":"A287","pred":"fma_id","subj":"T287","obj":"http://purl.org/sig/ont/fma/fma7203"},{"id":"A288","pred":"fma_id","subj":"T288","obj":"http://purl.org/sig/ont/fma/fma7203"},{"id":"A289","pred":"fma_id","subj":"T289","obj":"http://purl.org/sig/ont/fma/fma7203"},{"id":"A290","pred":"fma_id","subj":"T290","obj":"http://purl.org/sig/ont/fma/fma7203"},{"id":"A291","pred":"fma_id","subj":"T291","obj":"http://purl.org/sig/ont/fma/fma7203"},{"id":"A292","pred":"fma_id","subj":"T292","obj":"http://purl.org/sig/ont/fma/fma7203"},{"id":"A293","pred":"fma_id","subj":"T293","obj":"http://purl.org/sig/ont/fma/fma7203"}],"text":"nical status at Day 15, hospital discharge time, all cause of death, duration of mechanical ventilation, duration of pressors, duration of ECMO, duration of oxygen therapy, length of hospital stay, absolute lymphocyte count NCT04317040/Not yet recruiting,May‐May 2020–2022\nAcute kidney injury in patients hospitalized with COVID‐19 – China/COVID‐19 acute kidney injury‐kidney function 287, all, 18 years and older Observational Acute kidney injury:\nCOVID‐19 patients with acute kidney injury\nnonacute kidney injury:\nCOVID‐19 patients without acute kidney injury –\nRate of death, the length of hospital stay Primary (up to 60 days):\nRate of acute kidney injury\nSecondary (up to 60 days): NCT04316299/Completed, Feb 26‐Mar8 2020\nPhase I clinical trial in healthy adult Logical: recombinant novel coronavirus vaccine (adenovirus type 5 vector) COVID‐19 108, all, 18–60 Treatment "}
LitCovid-PD-UBERON
{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T178","span":{"begin":280,"end":286},"obj":"Body_part"},{"id":"T179","span":{"begin":358,"end":364},"obj":"Body_part"},{"id":"T180","span":{"begin":372,"end":378},"obj":"Body_part"},{"id":"T181","span":{"begin":440,"end":446},"obj":"Body_part"},{"id":"T182","span":{"begin":484,"end":490},"obj":"Body_part"},{"id":"T183","span":{"begin":507,"end":513},"obj":"Body_part"},{"id":"T184","span":{"begin":554,"end":560},"obj":"Body_part"},{"id":"T185","span":{"begin":654,"end":660},"obj":"Body_part"}],"attributes":[{"id":"A178","pred":"uberon_id","subj":"T178","obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"A179","pred":"uberon_id","subj":"T179","obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"A180","pred":"uberon_id","subj":"T180","obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"A181","pred":"uberon_id","subj":"T181","obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"A182","pred":"uberon_id","subj":"T182","obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"A183","pred":"uberon_id","subj":"T183","obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"A184","pred":"uberon_id","subj":"T184","obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"A185","pred":"uberon_id","subj":"T185","obj":"http://purl.obolibrary.org/obo/UBERON_0002113"}],"text":"nical status at Day 15, hospital discharge time, all cause of death, duration of mechanical ventilation, duration of pressors, duration of ECMO, duration of oxygen therapy, length of hospital stay, absolute lymphocyte count NCT04317040/Not yet recruiting,May‐May 2020–2022\nAcute kidney injury in patients hospitalized with COVID‐19 – China/COVID‐19 acute kidney injury‐kidney function 287, all, 18 years and older Observational Acute kidney injury:\nCOVID‐19 patients with acute kidney injury\nnonacute kidney injury:\nCOVID‐19 patients without acute kidney injury –\nRate of death, the length of hospital stay Primary (up to 60 days):\nRate of acute kidney injury\nSecondary (up to 60 days): NCT04316299/Completed, Feb 26‐Mar8 2020\nPhase I clinical trial in healthy adult Logical: recombinant novel coronavirus vaccine (adenovirus type 5 vector) COVID‐19 108, all, 18–60 Treatment "}
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T455","span":{"begin":274,"end":293},"obj":"Disease"},{"id":"T456","span":{"begin":287,"end":293},"obj":"Disease"},{"id":"T457","span":{"begin":324,"end":332},"obj":"Disease"},{"id":"T458","span":{"begin":343,"end":351},"obj":"Disease"},{"id":"T459","span":{"begin":352,"end":371},"obj":"Disease"},{"id":"T460","span":{"begin":365,"end":371},"obj":"Disease"},{"id":"T461","span":{"begin":434,"end":453},"obj":"Disease"},{"id":"T462","span":{"begin":447,"end":453},"obj":"Disease"},{"id":"T463","span":{"begin":455,"end":463},"obj":"Disease"},{"id":"T464","span":{"begin":478,"end":497},"obj":"Disease"},{"id":"T465","span":{"begin":491,"end":497},"obj":"Disease"},{"id":"T466","span":{"begin":514,"end":520},"obj":"Disease"},{"id":"T467","span":{"begin":522,"end":530},"obj":"Disease"},{"id":"T468","span":{"begin":548,"end":567},"obj":"Disease"},{"id":"T469","span":{"begin":561,"end":567},"obj":"Disease"},{"id":"T470","span":{"begin":648,"end":667},"obj":"Disease"},{"id":"T471","span":{"begin":661,"end":667},"obj":"Disease"},{"id":"T472","span":{"begin":852,"end":860},"obj":"Disease"}],"attributes":[{"id":"A455","pred":"mondo_id","subj":"T455","obj":"http://purl.obolibrary.org/obo/MONDO_0002492"},{"id":"A456","pred":"mondo_id","subj":"T456","obj":"http://purl.obolibrary.org/obo/MONDO_0021178"},{"id":"A457","pred":"mondo_id","subj":"T457","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A458","pred":"mondo_id","subj":"T458","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A459","pred":"mondo_id","subj":"T459","obj":"http://purl.obolibrary.org/obo/MONDO_0002492"},{"id":"A460","pred":"mondo_id","subj":"T460","obj":"http://purl.obolibrary.org/obo/MONDO_0021178"},{"id":"A461","pred":"mondo_id","subj":"T461","obj":"http://purl.obolibrary.org/obo/MONDO_0002492"},{"id":"A462","pred":"mondo_id","subj":"T462","obj":"http://purl.obolibrary.org/obo/MONDO_0021178"},{"id":"A463","pred":"mondo_id","subj":"T463","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A464","pred":"mondo_id","subj":"T464","obj":"http://purl.obolibrary.org/obo/MONDO_0002492"},{"id":"A465","pred":"mondo_id","subj":"T465","obj":"http://purl.obolibrary.org/obo/MONDO_0021178"},{"id":"A466","pred":"mondo_id","subj":"T466","obj":"http://purl.obolibrary.org/obo/MONDO_0021178"},{"id":"A467","pred":"mondo_id","subj":"T467","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A468","pred":"mondo_id","subj":"T468","obj":"http://purl.obolibrary.org/obo/MONDO_0002492"},{"id":"A469","pred":"mondo_id","subj":"T469","obj":"http://purl.obolibrary.org/obo/MONDO_0021178"},{"id":"A470","pred":"mondo_id","subj":"T470","obj":"http://purl.obolibrary.org/obo/MONDO_0002492"},{"id":"A471","pred":"mondo_id","subj":"T471","obj":"http://purl.obolibrary.org/obo/MONDO_0021178"},{"id":"A472","pred":"mondo_id","subj":"T472","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"nical status at Day 15, hospital discharge time, all cause of death, duration of mechanical ventilation, duration of pressors, duration of ECMO, duration of oxygen therapy, length of hospital stay, absolute lymphocyte count NCT04317040/Not yet recruiting,May‐May 2020–2022\nAcute kidney injury in patients hospitalized with COVID‐19 – China/COVID‐19 acute kidney injury‐kidney function 287, all, 18 years and older Observational Acute kidney injury:\nCOVID‐19 patients with acute kidney injury\nnonacute kidney injury:\nCOVID‐19 patients without acute kidney injury –\nRate of death, the length of hospital stay Primary (up to 60 days):\nRate of acute kidney injury\nSecondary (up to 60 days): NCT04316299/Completed, Feb 26‐Mar8 2020\nPhase I clinical trial in healthy adult Logical: recombinant novel coronavirus vaccine (adenovirus type 5 vector) COVID‐19 108, all, 18–60 Treatment "}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T704","span":{"begin":280,"end":286},"obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"T705","span":{"begin":280,"end":286},"obj":"http://www.ebi.ac.uk/efo/EFO_0000927"},{"id":"T706","span":{"begin":280,"end":286},"obj":"http://www.ebi.ac.uk/efo/EFO_0000929"},{"id":"T707","span":{"begin":358,"end":364},"obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"T708","span":{"begin":358,"end":364},"obj":"http://www.ebi.ac.uk/efo/EFO_0000927"},{"id":"T709","span":{"begin":358,"end":364},"obj":"http://www.ebi.ac.uk/efo/EFO_0000929"},{"id":"T710","span":{"begin":372,"end":378},"obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"T711","span":{"begin":372,"end":378},"obj":"http://www.ebi.ac.uk/efo/EFO_0000927"},{"id":"T712","span":{"begin":372,"end":378},"obj":"http://www.ebi.ac.uk/efo/EFO_0000929"},{"id":"T713","span":{"begin":399,"end":401},"obj":"http://purl.obolibrary.org/obo/CLO_0050510"},{"id":"T714","span":{"begin":440,"end":446},"obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"T715","span":{"begin":440,"end":446},"obj":"http://www.ebi.ac.uk/efo/EFO_0000927"},{"id":"T716","span":{"begin":440,"end":446},"obj":"http://www.ebi.ac.uk/efo/EFO_0000929"},{"id":"T717","span":{"begin":484,"end":490},"obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"T718","span":{"begin":484,"end":490},"obj":"http://www.ebi.ac.uk/efo/EFO_0000927"},{"id":"T719","span":{"begin":484,"end":490},"obj":"http://www.ebi.ac.uk/efo/EFO_0000929"},{"id":"T720","span":{"begin":507,"end":513},"obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"T721","span":{"begin":507,"end":513},"obj":"http://www.ebi.ac.uk/efo/EFO_0000927"},{"id":"T722","span":{"begin":507,"end":513},"obj":"http://www.ebi.ac.uk/efo/EFO_0000929"},{"id":"T723","span":{"begin":554,"end":560},"obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"T724","span":{"begin":554,"end":560},"obj":"http://www.ebi.ac.uk/efo/EFO_0000927"},{"id":"T725","span":{"begin":554,"end":560},"obj":"http://www.ebi.ac.uk/efo/EFO_0000929"},{"id":"T726","span":{"begin":654,"end":660},"obj":"http://purl.obolibrary.org/obo/UBERON_0002113"},{"id":"T727","span":{"begin":654,"end":660},"obj":"http://www.ebi.ac.uk/efo/EFO_0000927"},{"id":"T728","span":{"begin":654,"end":660},"obj":"http://www.ebi.ac.uk/efo/EFO_0000929"},{"id":"T729","span":{"begin":872,"end":874},"obj":"http://purl.obolibrary.org/obo/CLO_0050510"}],"text":"nical status at Day 15, hospital discharge time, all cause of death, duration of mechanical ventilation, duration of pressors, duration of ECMO, duration of oxygen therapy, length of hospital stay, absolute lymphocyte count NCT04317040/Not yet recruiting,May‐May 2020–2022\nAcute kidney injury in patients hospitalized with COVID‐19 – China/COVID‐19 acute kidney injury‐kidney function 287, all, 18 years and older Observational Acute kidney injury:\nCOVID‐19 patients with acute kidney injury\nnonacute kidney injury:\nCOVID‐19 patients without acute kidney injury –\nRate of death, the length of hospital stay Primary (up to 60 days):\nRate of acute kidney injury\nSecondary (up to 60 days): NCT04316299/Completed, Feb 26‐Mar8 2020\nPhase I clinical trial in healthy adult Logical: recombinant novel coronavirus vaccine (adenovirus type 5 vector) COVID‐19 108, all, 18–60 Treatment "}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T341","span":{"begin":117,"end":125},"obj":"Chemical"},{"id":"T342","span":{"begin":157,"end":163},"obj":"Chemical"}],"attributes":[{"id":"A341","pred":"chebi_id","subj":"T341","obj":"http://purl.obolibrary.org/obo/CHEBI_137431"},{"id":"A342","pred":"chebi_id","subj":"T342","obj":"http://purl.obolibrary.org/obo/CHEBI_25805"}],"text":"nical status at Day 15, hospital discharge time, all cause of death, duration of mechanical ventilation, duration of pressors, duration of ECMO, duration of oxygen therapy, length of hospital stay, absolute lymphocyte count NCT04317040/Not yet recruiting,May‐May 2020–2022\nAcute kidney injury in patients hospitalized with COVID‐19 – China/COVID‐19 acute kidney injury‐kidney function 287, all, 18 years and older Observational Acute kidney injury:\nCOVID‐19 patients with acute kidney injury\nnonacute kidney injury:\nCOVID‐19 patients without acute kidney injury –\nRate of death, the length of hospital stay Primary (up to 60 days):\nRate of acute kidney injury\nSecondary (up to 60 days): NCT04316299/Completed, Feb 26‐Mar8 2020\nPhase I clinical trial in healthy adult Logical: recombinant novel coronavirus vaccine (adenovirus type 5 vector) COVID‐19 108, all, 18–60 Treatment "}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T742","span":{"begin":274,"end":454},"obj":"Sentence"},{"id":"T743","span":{"begin":455,"end":497},"obj":"Sentence"},{"id":"T744","span":{"begin":498,"end":521},"obj":"Sentence"},{"id":"T745","span":{"begin":522,"end":570},"obj":"Sentence"},{"id":"T746","span":{"begin":571,"end":639},"obj":"Sentence"},{"id":"T747","span":{"begin":640,"end":667},"obj":"Sentence"},{"id":"T748","span":{"begin":668,"end":735},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"nical status at Day 15, hospital discharge time, all cause of death, duration of mechanical ventilation, duration of pressors, duration of ECMO, duration of oxygen therapy, length of hospital stay, absolute lymphocyte count NCT04317040/Not yet recruiting,May‐May 2020–2022\nAcute kidney injury in patients hospitalized with COVID‐19 – China/COVID‐19 acute kidney injury‐kidney function 287, all, 18 years and older Observational Acute kidney injury:\nCOVID‐19 patients with acute kidney injury\nnonacute kidney injury:\nCOVID‐19 patients without acute kidney injury –\nRate of death, the length of hospital stay Primary (up to 60 days):\nRate of acute kidney injury\nSecondary (up to 60 days): NCT04316299/Completed, Feb 26‐Mar8 2020\nPhase I clinical trial in healthy adult Logical: recombinant novel coronavirus vaccine (adenovirus type 5 vector) COVID‐19 108, all, 18–60 Treatment "}
LitCovid-PD-HP
{"project":"LitCovid-PD-HP","denotations":[{"id":"T250","span":{"begin":274,"end":293},"obj":"Phenotype"},{"id":"T251","span":{"begin":352,"end":371},"obj":"Phenotype"},{"id":"T252","span":{"begin":434,"end":453},"obj":"Phenotype"},{"id":"T253","span":{"begin":478,"end":497},"obj":"Phenotype"},{"id":"T254","span":{"begin":548,"end":567},"obj":"Phenotype"},{"id":"T255","span":{"begin":648,"end":667},"obj":"Phenotype"}],"attributes":[{"id":"A250","pred":"hp_id","subj":"T250","obj":"http://purl.obolibrary.org/obo/HP_0001919"},{"id":"A251","pred":"hp_id","subj":"T251","obj":"http://purl.obolibrary.org/obo/HP_0001919"},{"id":"A252","pred":"hp_id","subj":"T252","obj":"http://purl.obolibrary.org/obo/HP_0001919"},{"id":"A253","pred":"hp_id","subj":"T253","obj":"http://purl.obolibrary.org/obo/HP_0001919"},{"id":"A254","pred":"hp_id","subj":"T254","obj":"http://purl.obolibrary.org/obo/HP_0001919"},{"id":"A255","pred":"hp_id","subj":"T255","obj":"http://purl.obolibrary.org/obo/HP_0001919"}],"text":"nical status at Day 15, hospital discharge time, all cause of death, duration of mechanical ventilation, duration of pressors, duration of ECMO, duration of oxygen therapy, length of hospital stay, absolute lymphocyte count NCT04317040/Not yet recruiting,May‐May 2020–2022\nAcute kidney injury in patients hospitalized with COVID‐19 – China/COVID‐19 acute kidney injury‐kidney function 287, all, 18 years and older Observational Acute kidney injury:\nCOVID‐19 patients with acute kidney injury\nnonacute kidney injury:\nCOVID‐19 patients without acute kidney injury –\nRate of death, the length of hospital stay Primary (up to 60 days):\nRate of acute kidney injury\nSecondary (up to 60 days): NCT04316299/Completed, Feb 26‐Mar8 2020\nPhase I clinical trial in healthy adult Logical: recombinant novel coronavirus vaccine (adenovirus type 5 vector) COVID‐19 108, all, 18–60 Treatment "}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"1953","span":{"begin":297,"end":305},"obj":"Species"},{"id":"1954","span":{"begin":464,"end":472},"obj":"Species"},{"id":"1955","span":{"begin":531,"end":539},"obj":"Species"},{"id":"1956","span":{"begin":798,"end":815},"obj":"Species"},{"id":"1957","span":{"begin":825,"end":842},"obj":"Species"}],"attributes":[{"id":"A1953","pred":"tao:has_database_id","subj":"1953","obj":"Tax:9606"},{"id":"A1954","pred":"tao:has_database_id","subj":"1954","obj":"Tax:9606"},{"id":"A1955","pred":"tao:has_database_id","subj":"1955","obj":"Tax:9606"},{"id":"A1956","pred":"tao:has_database_id","subj":"1956","obj":"Tax:2697049"},{"id":"A1957","pred":"tao:has_database_id","subj":"1957","obj":"Tax:28285"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"nical status at Day 15, hospital discharge time, all cause of death, duration of mechanical ventilation, duration of pressors, duration of ECMO, duration of oxygen therapy, length of hospital stay, absolute lymphocyte count NCT04317040/Not yet recruiting,May‐May 2020–2022\nAcute kidney injury in patients hospitalized with COVID‐19 – China/COVID‐19 acute kidney injury‐kidney function 287, all, 18 years and older Observational Acute kidney injury:\nCOVID‐19 patients with acute kidney injury\nnonacute kidney injury:\nCOVID‐19 patients without acute kidney injury –\nRate of death, the length of hospital stay Primary (up to 60 days):\nRate of acute kidney injury\nSecondary (up to 60 days): NCT04316299/Completed, Feb 26‐Mar8 2020\nPhase I clinical trial in healthy adult Logical: recombinant novel coronavirus vaccine (adenovirus type 5 vector) COVID‐19 108, all, 18–60 Treatment "}